Curriculum vitae susan m. Miller, M. D., M. P. H
Download 145.62 Kb.
|
- Navigate this page:
- B. EDUCATIONAL BACKGROUND
- State Number Date of Issue Date of last registration
- G. INSTITUTIONAL/HOSPITAL AFFILIATION
- I. CURRENT AND PAST INSTITUTIONAL RESPONSIBILITIES AND PERCENT EFFORT
- Research Dates
- Research______________ 30_
- K. EXTRAMURAL PROFESSIONAL RESPONSIBILITIES
| CURRICULUM VITAE
SUSAN M. MILLER, M.D., M.P.H. Information: Office Address: Department of Medicine TMHPO-Methodist Academic Medicine Associates 6550 Fannin, Suite 1001 Houston, Texas 77030
Office Telephone: 713-441-2750 Office Fax: 713-790-3013 Email: smmiller@houstonmethodist.org Citizenship: USA Optional Information: Birth Date: December 2, 1957 Birthplace: Galveston TX
Children’s names and ages: David Dore, Stephen Dore Race/Ethnicity: Caucasian
Center at Houston, C. PROFESSIONAL POSITIONS AND EMPLOYMENT Post-doctoral training including residency/fellowship Title Institution Name, city and state Dates Resident University of Texas Health Science 1983-1986 Family Practice Center at Houston Academic positions (teaching and research) Title Institution Name, city and state Dates Professor of Clinical Institute of Academic Medicine, 7/2014 – present Family Medicine Houston Methodist Hospital Research Institute John S. Dunn, Sr. Research Houston Methodist Hospital 7/2014 - present Chair in General Internal Medicine
Academy of Family Physicians 6/2014 – present Grant Manager Center for Medicine After the Holocaust 7/2014 – 4/2015 Associate Professor of Weill Medical College, Cornell University 5/2006 – present Clinical Medicine Director, Chao Program for International Research 2/2011 - present Ethics
Department of Institutional Review Ethics and Administration, Nicholas Cardinal Cheong Graduate School
of Bioethics – Ukraine Co-Founder Physicians after the Holocaust – Ukraine 2013 – present Research Associate Professor University of Houston 6/2005 – 2010 Adjunct Faculty Institute of Religion and Health 12/2005 – 2008 Faculty member Denver Harbor Clinic 8/2006 – present Methodist Hospital Family Medicine Residency Program Deputy Chief, elected Methodist Hospital Family Medicine 2/2009 - present Service
Medicine Baylor College of Medicine
Baylor College of Medicine Medical Director Baylor Internal Medicine Consultants 7/1997 - 2000 Baylor College of Medicine Associate Chief Baylor College of Medicine 9/1997 – 6/2005 Department of Medicine Associate Professor Baylor College of Medicine 5/1997 – 6/2005 Department of Medicine Associate Professor Baylor College of Medicine 5/1997 - present Center for Ethics and Health Policy Assistant Professor Center for Medical Ethics and Health Policy 1996 - 1997 Assistant Professor Baylor College of Medicine 1988 - 1997 Departments of Family Medicine and Department of Medicine Clinical Instructor University of Texas Health Science 1986 - 2001 Center at Houston Family Medicine and Community Medicine Hospital positions (attending physician, if applicable) Title Institution Name, city and state Date Staff Physician The Methodist Hospital 1990-present Houston, Texas Staff Physician Harris County Hospital District 1990-6/2005 Thomas Street Clinic
Courtesy Staff Houston, Texas Courtesy Staff Texas Children's Hospital 1989-1995 Houston, Texas Courtesy Staff Hermann Hospital 1988-1995 Houston, Texas Staff Physician Jefferson Davis Hospital 1988-1990 Houston, Texas Employment (other than positions listed above) Title Institution Name, city and state Dates N/A D. LICENSURE, BOARD CERTIFICATION, MALPRACTICE (if applicable) LicensureState Number Date of Issue Date of last registrationTexas G 6675 1986 to present January 2014 DEA Number: AM 2883343 Board CertificationName of specialty Board Certificate Number Date of CertificationAmerican Board of Family Practice 1986 Recertification 1992/1998/2004/2014
Sexually Transmitted Diseases Committee August 1990 - 1992 Member Harris County Medical Association 1989 – 2010 F. HONORS AND AWARDSName of award Date awarded University of Missouri-Columbia Family Practice Award 1983 Macadory Award 1993 The Best Doctors in America 1996, 1997, 1998, 2001, 2002, 2003, 2004, 2007, 2009, 2010, 2011, 2012, 2013, 2014 American College of Physicians, member 1996-present Humanitarian Award (Philippine community) 1999 Honorary Faculty Appointment, Tomsk Regional Center for AIDS and 2000-present Other Infectious Diseases, Tomsk Siberia Voluntary faculty teaching award, Denver Harbor Clinic 2007 Faculty teaching Award, Denver Harbor Clinic 2010 Fellow of the American Academy of Family Physicians (FAAFP) 2014
Primary Hospital Affiliation: The Methodist Hospital Other Hospital Affiliations: St. Luke’s Episcopal Hospital
H. EMPLOYMENT STATUSName of Employer(s): TMHPO Employment Status: Full timed salaried at Houston Methodist Hospital Physician’s Organization
Internal Medicine Teaching Service 1991-6/2005 Patient, physician and society (PPS) course. 1995 - 1996 First year course in Medical Ethics. 1995 - present Internal Medicine Board Review Course. 1995 – 1998 Honors Ethics 1998 - 2005 Ethics and HIV, Tomsk Regional Center for AIDS and Other Infectious Diseases Tomsk, Russia 1998-present International Health and Electives (BCM) 2001-present International Health, Rice University 2004-present Denver Harbor Clinic 2007-present Primary Care Continuity Clinic 2010-present CURRICULUM DEVELOPMENT WORK Co-Director, Baylor College of Medicine, Family and Community Medicine Clerkship, 1988-1990. Director, Baylor College of Medicine, Family and Community Medicine Clerkship, 1990-1992. Member, Collaborative IRB Training Initiative (CITI) Developers Group 2007-present Clinical Care Dates TMHPO - Comprehensive Health Service 6/2005-2009 TMHPO - Methodist Academic Medicine Associates 2009-present Denver Harbor Clinic 2008-present
Medicine Service Line Committee – Methodist Hospital 2000-2004 Credentialing Committee Methodist Care/Unicare/Wellpoint 1999-2009 Medical Staff Quality Management Committee Methodist Hospital 1998-2004 Chair 2004-2008 Chair 2015-present P &T MOM Subcommittee/Medication Safety Committee 2005-present Patient Safety CMPI Subcommittee 2005-present Biomedical Ethics Committee, TMH 2007-present Chair, Institutional Review Board, TMHRI IRB #1 2006-present Vice-Chair, Institutional Review Board, TMHRI IRB #2 2010-present Utilization Management CMPI Subcommittee 2011-2015 Physician Satisfaction Goal Group 2011-present Physician Advisory Committee 2011-present DNV Steering Committee 2011-2014 Quality and Outcomes Strategic Planning Subcommittee, TMHRI 2013 Chair, Vehicles for Intervention I: Education, Adoption, Follow-up & Risk Management Planning Subcommittee, TMHRI, 2013 METEOR data governance committee 2013 - present Medication Safety Squad – TMH 2008-2010 Chair, Medication-related Patient Safety Network team 2012-present Co-chair, Medication Safety Committee 2014-present Radiation Safety Committee 2008-present Practitioner Health Committee – TMH 2011-present TMH – Peer Review 2013-present Medical Director and Women's Health Initiative Co-Principal Investigator 1997-2004
Chair, 1995-2000 BCM Committee on AIDS 1995–1997 Medicine-Pediatrics Program Committee 1995–2005 Executive Faculty - Internal Medicine 1994-2003 Ethics Committee, HCHD 1992-1997 Adverse Drug Reaction Subcommittee, HCHD 1992-1997 Pharmacy & Therapeutics Committee, HCHD 1991-1997 Antibiotic Subcommittee, HCHD 1991-1997 15th Annual Review Course in Family Medicine, Houston, Texas April 29 - May 3, 1991 Co-Director Medical Director 1991-1997 Thomas Street Clinic Ad Hoc Committee on AIDS 1990-1996 Baylor Needlestick Program 1990-1996 Baylor College of Medicine 1989–1992 Institutional Review Board (Human Subjects) Committee Member
Member
Pre-doctoral Education Program Co-Director 1988-1990 Director 1990-1992 Staff Physician & Co-Investigator 1987-1988 Institute for Immunological Disorders Houston, Texas Research DatesPrevention and Treatment of HIV/AIDS in Adults and Children (RO3 AI 058251-01 $106,908) Consultant (Tomsk Siberia) 2004-present HIV Risk Factors and Reduction of MTCT in Tomsk, Siberia (3P30 AI 036211-10S1 ($30,000) consultant 2005-present Developer’s Council – CITI 2007-present Executive Advisory Committee – CITI 2010-2013 Executive Advisory Board – CITI 2013-present Vice Chairman 2014-present Board of Directors, CMATH 2014-present Current percent effort % Check if activity involves WMC Students researchers Teaching 10 Clinical Care 10 Administration 50 Research______________ 30_Total: 100% J. RESEARCH SUPPORT (past and present) 1. Catalog of Federal Domestic Assistance No. 13.379 Grants for Graduate Training in Family Medicine USHHS/PHS/HRSA Co-Investigator July, 1989 - June, 1992 Year 1: $386,872 Project: $977,932 Training Grant 2. A randomized, double-blind, comparative study of RO24-2027 (dideoxycytidine, ddC) versus zidovudine (zdv) in patients with AIDS or advanced ARC Hoffman LaRoche Co-Investigator August 1989-1991 3. A Treatment IND Protocol for the use of Videx (2'3'dideoxyinosine, ddI) in Patients with Acquired Immunodeficiency Syndrome (AIDS) or AIDS - related complex (ARC) who are Intolerant to Zidovudine (Retrovir) Bristol Myers Principal Investigator November 1989-1991
Pfizer
Co-Investigator (with Dr. Clinton White) December 1989-1991 5. Ceftriaxone versus procaine penicillin G plus probenecid as therapy for secondary or latent syphilis or neurosyphilis in patients infected with human immuno-deficiency virus (HIV) Thomas Street Clinic Co-Investigator (with Dr. Clinton White) 1989-1992 6. Ampligen Research Study: a. Use of Ampligen (mismatched ds RNA) in the Treatment of AIDS-related Complex (ARC). Clinical Protocol: No. Amp 86-101 b. A Multicenter Controlled Study of the Efficacy and Safety of Ampligen in Patients with AIDS-related Immune Dysfunction. Clinical Protocol: No. 101 c. A Multicenter Study of the Efficacy and Safety of Ampligen 400 mg IV Twice Weekly in Patients with AIDS. Clinical Protocol: No. Amp 101A HEM Research Inc. Principal Investigator August 1988 - July, 1989 Approved Budget: $230,431 Research Contract
HIV Education Training Grant USHHS/PHS/HRSA Sr. AIDS Consultant September, 1988 - August, 1991 Year 1: $801,000 Project: $2,963,000 Training Grant
Component (ACT6 Protocol 129) Co-Investigator (with Dr. Richard Lewis) 1990-1991 9. Rifabutin therapy for the prevention of mycobacterium-avium intracellular complex (MAC) bacteremia in AIDS patients with cd4 counts <200: a double-blind, placebo controlled trial Adria Laboratories Principal Investigator September1990-1992 10. A Phase II open randomized comparison of 566C80 and pentamidine isethionate for the treatment of Pneumocystis carini pneumonia in aids patients Part I: Comparison of 566C80 and pentamidine as primary therapy for mild-moderate PCP Part II: Comparison of 566C80 and pentamidine in patients currently experiencing intolerance Burroughs Wellcome Company Co-Investigator (with Dr. Stephen Greenberg) February 1991-1992
NIAID
Co-Investigator (for Dr. Richard Lewis) February 1991-1993 12. TB and HIV demonstration project - trial preventive therapy efficacy study (U52/CCU 601867) CDC
Co-Investigator (at Harris County Hospital District) July 1991-1993 13. TB and HIV demonstration project - recommended therapy efficacy study (U51/CCU 601868) CDC
Co-Investigator (at Harris County Hospital District) July 1991-1993 14. Pilot study to determine the feasibility of fluconazole for induction treatment and suppression of relapse of histoplasmosis in patients with the Acquired Immunodeficiency Syndrome NIAID, Pfizer/Roerig Pharmaceuticals Co-Investigator (with Dr. Clinton White) September 1991-1993 15. A randomized double-blind protocol comparing amphotericin B with flucytosine to amphotericin B alone followed by a comparison of fluconazole and itraconazole in the treatment of acute cryptococcal meningitis NIAID, Pfizer-Roerig Co-Investigator September 1991-1993 16. Controlled trial of humatin (Paromomycin) in cryptosporidiosis Thomas Street Clinic Co-Investigator October 1991 to 1993 17. A comparative trial of 256U87 and acyclovir for the suppression of ano-genital herpes infections in HIV-infected patients Burroughs Wellcome Company Co-Investigator (with Dr. Stephen Greenberg) March 1992-March 1993 18. Catalog of Federal Domestic Assistance No. 93.379 Grants for Graduate Training in Family Medicine USHHS/PHS/HRSA Consultant July 1992 - June 1994 Approved Budget: $394,556 Training Grant 19. Open label dideoxycytidine (RO 24-2027). A treatment protocol for the use of dideoxycytidine (ddC) in patients with AIDS or advanced AIDS-related complex (ARC) who cannot be maintained on zidovudine (ZDV) therapy Hoffman-LaRoche Principal Investigator January 1992-1993
Co-Investigator (with Dr. Richard Lewis) 1992-1994
Co-Investigator (with Dr. Richard Lewis) 1992-1994
Principal Investigator February/1993/1998
Thomas Street Clinic Co-Investigator 1993-1998 24. LTI-30-10 Randomized comparative trial of DOXIL vs. Adriamycin, Bleomycin and Vincristine (ABV) in the treatment of severe AIDS related Kaposi's Sarcoma Liposome
Principal Investigator 1993 to 1995 Approved Budget: $11,802
25. A randomized, double-blind, multicenter, parallel study of RO31-8959 (HIV proteinase inhibitor) alone and with HIVID (zalcitabine, ddC) Hoffman-LaRoche Principal Investigator January 1994 - January 1995
Hoffman-LaRoche Principal Investigator September 1994 - September 1997 Approved Budget: $53,000
Women's Health Initiative - West. NIH - WHI-93-30-W Co-Investigator/Medical Director September 1994 - August 2005 Approved Budget: $522,806 28. LTI-30-25 Use of DOXIL 1 (stealth liposomal doxorubicin HC1) in the treatment of moderate to severe AIDS-related Kaposi's Sarcoma Liposome
Principal Investigator 1994 to 1995 29. LTI-30-12 open trial of DOXIL (Stealth Liposomal Doxorubicin HCI) in the treatment of moderate to severe AIDS-related Kaposi's Sarcoma Liposome
Principal Investigator 1994 to 1995 Approved Budget: $24,584
Rand Corporation Principal Investigator June 1994 to 1998 Approved Budget: $20,000
Thomas Street Clinic Co-Investigator 1994 – 1995 32. HPMPC Peripheral CMV Retinitis Trial Protocol (SOCA)
Co-Investigator (with Dr. Richard Lewis) 1994-1996 33. A randomized, multicenter, double-blind, phase III, parallel study of RO 31-8959 (HIV proteinase inhibitor) alone, HIVID (zalcitabine, ddC) alone, and both in combination, at two different dose levels of RO 31-8959, as treatment for advanced HIV infection (CD4 > 50 and < 300 cells/mm) in patients discontinuing or unable to take Retrovir (zidovudine, ZDV) therapy Hoffman-LaRoche Principal Investigator January 1995 - January 1996 Approved Budget: $146,000
Hoffman-LaRoche Principal Investigator November 1995 - November 1997 35. Intercompany collaboration for AIDS drug development. (ICC 002) Thomas Street Clinic Sub-Investigator (for Dr. Michael Lambert) November 1995-1996 36. A non-comparative, multisite, open-label, 48-week study to monitor the safety and tolerability of MK-0639 (indivanvir sulfate) 800mg Q8H administered as monotherapy or in combination with reverse transcriptase inhibitor therapy for the treatment of HIV-1 infection in advanced AIDS patients (patients with CD4 counts < 50 cells/mm). Thomas Street Clinic Co-Investigator 1995 - 1998 37. NV15182 - A randomized, placebo-controlled, double-blind, parallel group, multicenter study with open-label extension, of the safety and activity of Saquinavir soft gelatin capsule formulation (Saquinavir-SGC) in combination with other antiretroviral drugs Hoffmann-LaRoche Principal Investigator June 1995 to June 1997 Approved Budget: $35,000
38. SEQUUS 30-38 - Double-blind, randomized evaluation of clinical benefits in patients treated with DOXIL or DaunoXome whose AIDS related Kaposi's Sarcoma progressed on prior systemic combination chemotherapy SEQUUS Pharmaceuticals Principal Investigator September 1996 to September 1997 Approved Budget: $60,000 39. A phase II, randomized, double-blind, placebo-controlled study of the safety and efficacy of VIRACEPT in combination with antiretroviral therapy in HIV positive women with < 1 month of prior treatment with Stavudine (d4T) and/or Lamivudine (3TC) Agouron Pharmaceuticals Principal Investigator October 1996 - present Approved Budget: $84,888
HIV Risk Factors in Women in Tomsk Siberia ($30,000) 42. Co-investigator: Embedded Ethics Program in the MICU and CVICU to Alleviate Moral Distress ($10,000) The Methodist Hospital 2012-present 43. Faculty member (Tuberculosis D43 submission, building a TB/HIV research infrastructure in Ho Chi Minh City, Vietnam; PI, Edward A, Graviss (TMHRI), 2013) K. EXTRAMURAL PROFESSIONAL RESPONSIBILITIESReview Panels Southern Medical Journal, 1989-1991 American Family Physician, 1989-1991 EmergindexR Data Base, 1989-1991 The Journal of Family Practice, 1992–2005
1990 - 1992 Burroughs Wellcome HIV Advisory Panel 1989 - 1993 HEALTH EDUCATION TECHNOLOGY Panel 1990 – 1992 CMATH, Houston, Texas (Champion) 2012 – present CITI – Board of Directors 2013 - present CITI – Executive Advisory Committee 2010 – 2013 CITI – Executive Advisory Board 2013 – present (Vice Chair, 2014 – present) CDC faculty liaison (March 2012 - present), editor of primary care training modules.
2013 - present Consultant HRSA HIV/AIDS: "Continuum of Care Workshop" August 28, 1992 HIV Speaker's Forum - World Health 1993 - 1998 Agouron Pharmaceuticals 1996 - 1998 Texas Department of Clinical Justice 1993 – 1994 NATIONAL EDUCATION OR VOLUNTARY HEALTH ORGANIZATION PARTICIPATION Ryan White Council, Houston, Texas, Member 1991-1996 AIDS Legislative Task Force Response Group University of Texas School of Public Health 1988 - 1990
1988 - 1992 Long Range Planning Committee - Greater Houston AIDS Alliance June 1989 - 1991 Diocesan AIDS Council May 1989 - 1992 Vice-Chair, 1990 – 1992 Shalom Zone 2001-2005
1991 - 1993 Institutional Review Board of the Houston Clinical Research Network, Member/1991-1992 Co-Chair: PRIMR Conference: International Research Ethics (November 5, 2013, Boston) COMMUNITY WORK Tour Physician, Houston Symphony Orchestra (European Tour) November 17 - December 8, 1992 Tour Physician, Houston Symphony Orchestra (Tokyo Tour) - July 1995 Harris County Medical Society. Medical Report on HIV for KNUZ Radio, 1995. Tour Physician, Houston Symphony Orchestra (European Tour) 02/97 to 03/97 Habitat for Humanity, Medical Director – Houston, June 14 – 19, 1998 Habitat for Humanity International, Medical Director – Philippines, March 21 – 28, 1999 Member, Board of Directors – Together in Hope (2012-present) Champion, CMATH (2012-14) Board Member, CMATH (2014-present) Interim board member (The Methodist Hospital Primary Care Group, 2013) L. BIBLIOGRAPHY Peer Reviewed Articles
Book Chapters
Other
Presentations: (Optional, not encouraged) “Holocaust Doctors” (University of Missouri Columbia, October 25, 2013, invited speaker to 30 year medical school reunion) “Healing by Killing: The Role of Medicine in the Holocaust” (November 16, 2013, American College of Physicians)
Signature:_________________________________ Date:__________________ Download 145.62 Kb. Share with your friends:
|